GUFICBIO — Gufic Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹37.17bn
- IN₹40.24bn
- IN₹8.20bn
Annual cashflow statement for Gufic Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 442 | 958 | 797 | 861 | 696 |
| Depreciation | |||||
| Non-Cash Items | 145 | 42.5 | 73.6 | 171 | 226 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 140 | -128 | -1,359 | -1,277 | 92.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 891 | 1,062 | -266 | -74.6 | 1,226 |
| Capital Expenditures | -142 | -875 | -1,876 | -1,127 | -755 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 57.1 | -71.4 | -31.3 | 103 | 47.5 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -85.1 | -946 | -1,907 | -1,024 | -708 |
| Financing Cash Flow Items | -134 | -50.3 | -81.2 | -152 | -230 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -786 | -62.4 | 2,343 | 824 | -372 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.4 | 54.1 | 170 | -275 | 146 |